FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved Upsher-Smith Laboratories’ supplemental application for cyclobenzaprine hydrochloride, enabling changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Disorders
• Musculoskeletal Pain

Drugs mentioned

• CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)